709.33
Meta Platforms Inc stock is traded at $709.33, with a volume of 20.05M.
It is down -3.72% in the last 24 hours and up +5.35% over the past month.
Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.
See More
Previous Close:
$736.72
Open:
$736.695
24h Volume:
20.05M
Relative Volume:
1.18
Market Cap:
$1.81T
Revenue:
$214.96B
Net Income/Loss:
$70.59B
P/E Ratio:
25.79
EPS:
27.5066
Net Cash Flow:
$48.25B
1W Performance:
-1.30%
1M Performance:
+5.35%
6M Performance:
+4.79%
1Y Performance:
-0.39%
Meta Platforms Inc Stock (META) Company Profile
Name
Meta Platforms Inc
Sector
Industry
Phone
650-543-4800
Address
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, RDDT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
META
Meta Platforms Inc
|
709.33 | 1.81T | 214.96B | 70.59B | 48.25B | 27.51 |
|
GOOGL
Alphabet Inc
|
340.59 | 4.17T | 446.32B | 244.21B | 53.27B | 19.91 |
|
GOOG
Alphabet Inc
|
336.91 | 4.12T | 446.32B | 244.21B | 53.27B | 19.91 |
|
SPOT
Spotify Technology Sa
|
530.46 | 109.05B | 20.32B | 3.16B | 3.82B | 12.55 |
|
RDDT
Reddit Inc
|
156.14 | 30.04B | 2.47B | 707.54M | 868.73M | 3.5267 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-26 | Reiterated | Monness Crespi & Hardt | Buy |
| Sep-25-26 | Reiterated | Canaccord Genuity | Buy |
| Sep-25-26 | Reiterated | Deutsche Bank | Buy |
| Sep-25-26 | Reiterated | Piper Sandler | Overweight |
| Sep-25-26 | Reiterated | TD Cowen | Buy |
| Sep-23-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Sep-21-26 | Reiterated | Wells Fargo | Overweight |
| Sep-10-26 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-27-26 | Reiterated | Rosenblatt | Buy |
| Aug-27-26 | Reiterated | Truist | Buy |
| Jul-30-26 | Reiterated | Monness Crespi & Hardt | Buy |
| Jul-16-26 | Resumed | Wedbush | Neutral |
| Jul-10-26 | Reiterated | Citizens | Mkt Outperform |
| Jul-07-26 | Upgrade | Erste Group | Hold → Buy |
| Jun-02-26 | Upgrade | Arete | Neutral → Buy |
| May-20-26 | Reiterated | Wells Fargo | Overweight |
| May-05-26 | Reiterated | Mizuho | Outperform |
| Apr-30-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-10-26 | Reiterated | Wolfe Research | Outperform |
| Apr-09-26 | Reiterated | Rosenblatt | Buy |
| Apr-02-26 | Downgrade | Erste Group | Buy → Hold |
| Mar-30-26 | Reiterated | Morgan Stanley | Overweight |
| Mar-05-26 | Downgrade | Arete | Buy → Neutral |
| Mar-05-26 | Upgrade | Erste Group | Hold → Buy |
| Feb-23-26 | Reiterated | Wells Fargo | Overweight |
| Jan-29-26 | Reiterated | Canaccord Genuity | Buy |
| Jan-29-26 | Reiterated | Cantor Fitzgerald | Overweight |
| Jan-29-26 | Reiterated | Deutsche Bank | Buy |
| Jan-29-26 | Reiterated | Evercore ISI | Outperform |
| Jan-29-26 | Reiterated | Guggenheim | Buy |
| Jan-29-26 | Reiterated | JP Morgan | Overweight |
| Jan-29-26 | Reiterated | Jefferies | Buy |
| Jan-29-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-29-26 | Reiterated | Mizuho | Outperform |
| Jan-29-26 | Reiterated | Monness Crespi & Hardt | Buy |
| Jan-29-26 | Reiterated | Morgan Stanley | Overweight |
| Jan-29-26 | Reiterated | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | Pivotal Research Group | Buy |
| Jan-29-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-29-26 | Reiterated | Roth Capital | Buy |
| Jan-29-26 | Reiterated | Stifel | Buy |
| Jan-29-26 | Reiterated | UBS | Buy |
| Jan-29-26 | Reiterated | Wedbush | Outperform |
| Jan-29-26 | Reiterated | Wells Fargo | Overweight |
| Jan-29-26 | Reiterated | Wolfe Research | Outperform |
| Jan-26-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-26-26 | Reiterated | Raymond James | Strong Buy |
| Jan-26-26 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Jan-23-26 | Reiterated | Stifel | Buy |
| Jan-13-26 | Reiterated | TD Cowen | Buy |
| Jan-12-26 | Reiterated | Wells Fargo | Overweight |
| Jan-08-26 | Reiterated | Cantor Fitzgerald | Overweight |
| Jan-08-26 | Reiterated | Guggenheim | Buy |
| Dec-04-25 | Upgrade | Arete | Neutral → Buy |
| Nov-24-25 | Initiated | BNP Paribas Exane | Outperform |
| Nov-10-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-30-25 | Reiterated | Barclays | Overweight |
| Oct-30-25 | Reiterated | Bernstein | Outperform |
| Oct-30-25 | Reiterated | BofA Securities | Buy |
| Oct-30-25 | Reiterated | Citigroup | Buy |
| Oct-30-25 | Reiterated | JP Morgan | Overweight |
| Oct-30-25 | Reiterated | Jefferies | Buy |
| Oct-30-25 | Reiterated | Mizuho | Outperform |
| Oct-30-25 | Reiterated | Monness Crespi & Hardt | Buy |
| Oct-30-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-30-25 | Reiterated | Piper Sandler | Overweight |
| Oct-30-25 | Reiterated | Stifel | Buy |
| Oct-30-25 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-20-25 | Reiterated | Oppenheimer | Outperform |
| Oct-07-25 | Reiterated | Wells Fargo | Overweight |
| Sep-30-25 | Initiated | Mizuho | Outperform |
| Jul-31-25 | Reiterated | BMO Capital Markets | Market Perform |
| Jul-31-25 | Reiterated | Bernstein | Outperform |
| Jul-31-25 | Reiterated | BofA Securities | Buy |
| Jul-31-25 | Reiterated | Citigroup | Buy |
| Jul-31-25 | Reiterated | Citizens JMP | Mkt Outperform |
| Jul-31-25 | Reiterated | JP Morgan | Overweight |
| Jul-31-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-31-25 | Reiterated | Monness Crespi & Hardt | Buy |
| Jul-31-25 | Reiterated | Morgan Stanley | Overweight |
| Jul-31-25 | Reiterated | Oppenheimer | Outperform |
| Jul-31-25 | Reiterated | Pivotal Research Group | Buy |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-31-25 | Reiterated | UBS | Buy |
| Jul-31-25 | Reiterated | Wedbush | Outperform |
| Jul-31-25 | Reiterated | Wells Fargo | Overweight |
| Jul-28-25 | Reiterated | Guggenheim | Buy |
| Jul-16-25 | Reiterated | Canaccord Genuity | Buy |
| Jul-03-25 | Upgrade | Needham | Underperform → Hold |
| Jun-26-25 | Reiterated | UBS | Buy |
| Jun-24-25 | Reiterated | Citigroup | Buy |
| May-01-25 | Reiterated | BofA Securities | Buy |
| May-01-25 | Reiterated | Citigroup | Buy |
| May-01-25 | Reiterated | Evercore ISI | Outperform |
| May-01-25 | Reiterated | Goldman | Buy |
| May-01-25 | Reiterated | Guggenheim | Buy |
| May-01-25 | Reiterated | JP Morgan | Overweight |
| May-01-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| May-01-25 | Reiterated | MoffettNathanson | Buy |
| May-01-25 | Reiterated | Monness Crespi & Hardt | Buy |
| May-01-25 | Reiterated | Morgan Stanley | Overweight |
| May-01-25 | Reiterated | Oppenheimer | Outperform |
| May-01-25 | Reiterated | Piper Sandler | Overweight |
| May-01-25 | Reiterated | Pivotal Research Group | Buy |
| May-01-25 | Reiterated | Raymond James | Strong Buy |
| May-01-25 | Reiterated | Rosenblatt | Buy |
| May-01-25 | Reiterated | Roth Capital | Buy |
| May-01-25 | Reiterated | Stifel | Buy |
| May-01-25 | Reiterated | Truist | Buy |
| May-01-25 | Reiterated | UBS | Buy |
| May-01-25 | Reiterated | Wedbush | Outperform |
| Apr-14-25 | Reiterated | Citigroup | Buy |
| Apr-10-25 | Reiterated | Piper Sandler | Overweight |
| Jan-30-25 | Upgrade | The Benchmark Company | Hold → Buy |
| Jan-23-25 | Reiterated | BofA Securities | Buy |
| Jan-22-25 | Reiterated | Cantor Fitzgerald | Overweight |
| Jan-06-25 | Reiterated | Jefferies | Buy |
| Jan-03-25 | Reiterated | Wolfe Research | Outperform |
| Oct-31-24 | Reiterated | Monness Crespi & Hardt | Buy |
| Oct-31-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-11-24 | Initiated | Scotiabank | Sector Perform |
| Oct-09-24 | Reiterated | Cantor Fitzgerald | Overweight |
| Oct-01-24 | Initiated | Pivotal Research Group | Buy |
| Sep-30-24 | Reiterated | Monness Crespi & Hardt | Buy |
| Sep-10-24 | Initiated | DA Davidson | Buy |
| Sep-05-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-01-24 | Reiterated | BofA Securities | Buy |
| Jul-19-24 | Reiterated | Oppenheimer | Outperform |
| Jul-16-24 | Initiated | Wolfe Research | Outperform |
| Jul-10-24 | Reiterated | TD Cowen | Buy |
| Jul-08-24 | Reiterated | Wells Fargo | Overweight |
| Jul-01-24 | Reiterated | Raymond James | Strong Buy |
| Jun-12-24 | Reiterated | BMO Capital Markets | Market Perform |
| May-02-24 | Initiated | Exane BNP Paribas | Underperform |
| Apr-25-24 | Reiterated | Oppenheimer | Outperform |
| Apr-15-24 | Reiterated | Citigroup | Buy |
| Apr-11-24 | Reiterated | Piper Sandler | Overweight |
| Apr-08-24 | Reiterated | Oppenheimer | Outperform |
| Apr-04-24 | Reiterated | Jefferies | Buy |
| Feb-02-24 | Reiterated | Guggenheim | Buy |
| Feb-02-24 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-02-24 | Reiterated | JP Morgan | Overweight |
| Feb-02-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-02-24 | Reiterated | Mizuho | Buy |
| Feb-02-24 | Reiterated | Monness Crespi & Hardt | Buy |
| Feb-02-24 | Reiterated | Morgan Stanley | Overweight |
| Feb-02-24 | Reiterated | Oppenheimer | Outperform |
| Feb-02-24 | Reiterated | Piper Sandler | Overweight |
| Feb-02-24 | Reiterated | ROTH MKM | Buy |
| Feb-02-24 | Reiterated | Raymond James | Strong Buy |
| Feb-02-24 | Reiterated | Robert W. Baird | Outperform |
| Feb-02-24 | Reiterated | Seaport Research Partners | Buy |
| Feb-02-24 | Reiterated | Stifel | Buy |
| Feb-02-24 | Reiterated | Susquehanna | Positive |
| Feb-02-24 | Reiterated | TD Cowen | Outperform |
| Feb-02-24 | Reiterated | UBS | Buy |
| Feb-02-24 | Reiterated | Wedbush | Outperform |
| Feb-02-24 | Reiterated | Wells Fargo | Overweight |
| Feb-02-24 | Reiterated | Wolfe Research | Outperform |
| Jan-23-24 | Reiterated | Citigroup | Buy |
| Jan-17-24 | Reiterated | Piper Sandler | Overweight |
| Jan-17-24 | Reiterated | Wells Fargo | Overweight |
| Jan-09-24 | Initiated | BMO Capital Markets | Market Perform |
| Dec-20-23 | Resumed | Raymond James | Strong Buy |
| Oct-24-23 | Initiated | Seaport Research Partners | Buy |
| Aug-22-23 | Initiated | Wedbush | Outperform |
| Aug-01-23 | Reiterated | Argus | Buy |
| Jul-28-23 | Upgrade | China Renaissance | Hold → Buy |
| Jul-27-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Jul-27-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-25-23 | Reiterated | Mizuho | Buy |
| Jul-25-23 | Upgrade | New Street | Neutral → Buy |
| Jul-19-23 | Reiterated | Jefferies | Buy |
| Jul-19-23 | Reiterated | Truist | Buy |
| Jul-17-23 | Reiterated | Credit Suisse | Outperform |
| Jul-17-23 | Reiterated | Goldman | Buy |
| Jul-17-23 | Reiterated | JMP Securities | Mkt Outperform |
| Jul-13-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jul-12-23 | Reiterated | Deutsche Bank | Buy |
| Jun-08-23 | Initiated | Wells Fargo | Equal Weight |
| May-15-23 | Upgrade | Loop Capital | Hold → Buy |
| Apr-27-23 | Reiterated | Credit Suisse | Outperform |
| Apr-27-23 | Reiterated | Deutsche Bank | Buy |
| Apr-27-23 | Reiterated | Evercore ISI | Outperform |
| Apr-27-23 | Reiterated | Goldman | Buy |
| Apr-27-23 | Reiterated | Guggenheim | Buy |
| Apr-27-23 | Reiterated | JMP Securities | Mkt Outperform |
| Apr-27-23 | Reiterated | JP Morgan | Overweight |
| Apr-27-23 | Reiterated | Mizuho | Buy |
| Apr-27-23 | Reiterated | Monness Crespi & Hardt | Buy |
| Apr-27-23 | Reiterated | Morgan Stanley | Overweight |
| Apr-27-23 | Reiterated | Oppenheimer | Outperform |
| Apr-27-23 | Reiterated | Piper Sandler | Overweight |
| Apr-27-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-27-23 | Reiterated | Raymond James | Outperform |
| Apr-27-23 | Reiterated | Robert W. Baird | Outperform |
| Apr-27-23 | Reiterated | Rosenblatt | Buy |
| Apr-27-23 | Reiterated | Stifel | Buy |
| Apr-27-23 | Reiterated | TD Cowen | Market Perform |
| Apr-27-23 | Reiterated | Truist | Buy |
| Apr-27-23 | Reiterated | Wolfe Research | Outperform |
View All
Meta Platforms Inc Stock (META) Latest News
Inflation Pressures Rise as Services Activity Weakens - Zacks Investment Research
First Week of Q3 Earnings in the Books - Zacks Investment Research
This Unstoppable Vanguard ETF Could Turn $500 Per Month Into $1 Million Over the Long Term - The Motley Fool
The Stock Market Is Doing Something for Only the 3rd Time in 156 Years, and History Is Clear a Crash May be Hiding in Plain Sight - The Motley Fool
Cathie Wood Is Buying Shares of This Bargain “Magnificent Seven” Stock Before Oct. 21. Should You? - The Motley Fool
CoreWeave Stock Is Crashing. This Could Be Great News for SpaceX Investors. - The Motley Fool
This Dividend King Is Getting In on the AI Energy Boom With Its Recent Deal with Google. Is It a Buy? - The Motley Fool
Billionaires Are Selling These 6 Artificial Intelligence (AI) Stocks. Should You Follow? - The Motley Fool
Prediction: A $10,000 Investment in This Artificial Intelligence (AI) Hardware Stock Will At Least Double by 2030 (Hint: It’s Not Nvidia or Micron) - The Motley Fool
SpaceX Has Climbed 15% From Its IPO Price. Here’s Where History Says It Will Be After 1 Year. - The Motley Fool
Not Nvidia. Not Cisco. This Is the AI Networking Stock Quietly Wiring Every Data Center - The Motley Fool
3 Chip Stocks to Buy Before Big Tech Reports Its Spending Plans - The Motley Fool
Why This Market Washout Will Spark a Year-End Rally - Zacks Investment Research
These 2 Stocks Have Run Circles Around the Magnificent Seven This Year, and Wall Street Says There Is More Upside Ahead - The Motley Fool
Is It Really "Safe" to Invest in Tech ETFs Right Now? Here's What History Suggests. - The Motley Fool
Form 4 Arista Networks For: 15 October By Investing.com - Investing.com Canada
Meta's Muse Agent Is a Massive Hit. I'm Still Not Sold on Meta Stock. - The Motley Fool
The Stock Market Will Look Completely Different by 2030. This Is the Stock I'm Buying Before It Does. - The Motley Fool
BLK Q3 Earnings Call Puts AI Financing and Fees in Focus - Zacks Investment Research
Big Tech Will Spend $745 Billion on AI This Year. These Stocks Get Paid on Every Dollar. - The Motley Fool
INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP AnnouncesHIMS - GlobeNewswire Inc.
Agentic AI Could Push This Trillion-Dollar Chipmaker to New Heights, According to Wall Street Analysts - The Motley Fool
Is Vident U.S. Equity Strategy ETF (VUSE) a Strong ETF Right Now? - Zacks Investment Research
Apple Could Dominate the Agentic AI Market With Siri. Just Not This Siri. - The Motley Fool
Not Memory. Not Energy. This Is the Biggest Bottleneck in Artificial Intelligence, and These Are the Companies That Can Benefit. - The Motley Fool
The Stock Market Is Echoing a Warning From the Dot-Com Bubble, and History Says Investors Should Make This 1 Move - The Motley Fool
Meta Platforms, Inc. (META) Stock Price, News, Quote & History - Yahoo! Finance Canada
Anthropic Just Became the First Company in History To Reach This Milestone. Here's What It Means for AI Stocks - The Motley Fool
Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action - GlobeNewswire Inc.
Meta Platforms (META) COO and related entities sell shares at $728.10 under a trading plan - Stock Titan
Jim Cramer Calls CoreWeave the "Real Deal," but the Stock Crashed 15% the Very Next Day. Should You Buy the Dip? - The Motley Fool
Form 144 Meta Platforms For: 14 October By Investing.com - Investing.com Nigeria
Form 4 Meta Platforms Inc For: 14 October By Investing.com - Investing.com Nigeria
Musings About the Agentic Future - The Motley Fool
3 Trillion-Dollar Giants That Could Be the Next Big Stock-Split Plays - The Motley Fool
Nvidia Talked Up Generative AI 2 Weeks Before ChatGPT. The Clues Hold Up. - The Motley Fool
Should You Buy Alphabet Before Oct. 28? - The Motley Fool
Zacks Investment Ideas feature highlights: Meta Platform, Micron, SK Hynix, SanDisk and and ASML - Zacks Investment Research
Prediction: $5,000 Invested in Taiwan Semiconductor Could Be Worth This Much by 2030 - The Motley Fool
Alphabet vs. Meta Platforms: Here's What Revenue Trends Tell Investors About These Media Giants Turned Artificial Intelligence Companies - The Motley Fool
Form 4 Alphabet Inc Class A For: 14 October By Investing.com - Investing.com Canada
Why the Market Dipped But Meta Platforms (META) Gained Today - Zacks Investment Research
Bull Market Just Completed Year 4. Will It Finish Year 5? Here's What History Says. - The Motley Fool
Bearish AI Headlines: An Artificial Wave of Panic - Zacks Investment Research
Is Meta Platforms Stock Heading for $1,000? - The Motley Fool
Is Oklo Stock Your Ticket to Becoming a Millionaire? - The Motley Fool
AppLovin vs. Reddit: Which Technology Stock Is a Better Buy in 2026? - The Motley Fool
Meta Platforms Rises 12% in 3 Months: Buy, Sell, or Hold the Stock? - Zacks Investment Research
Meta Platforms, Inc. (META) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
Broadcom vs. Nvidia: The AI Revolution Is Big Enough for Both. Here's the Better Buy. - The Motley Fool
Meta Platforms Inc Stock (META) Financials Data
Revenue
Net Income
Cash Flow
EPS
Meta Platforms Inc Stock (META) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Olivan Javier | Chief Operating Officer |
Oct 12 '26 |
Sale |
728.10 |
629 |
457,975 |
1,004 |
| Olivan Javier | Officer |
Oct 12 '26 |
Proposed Sale |
728.10 |
1,575 |
1,146,757 |
0 |
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
629 |
457,962 |
1,061 |
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
946 |
688,764 |
7,878 |
| Olivan Javier | Officer |
Oct 05 '26 |
Proposed Sale |
728.08 |
1,575 |
1,146,726 |
0 |
| Olivan Javier | Chief Operating Officer |
Sep 28 '26 |
Sale |
748.91 |
629 |
471,064 |
1,118 |
| Olivan Javier | Officer |
Sep 28 '26 |
Proposed Sale |
749.82 |
1,575 |
1,180,966 |
0 |
| Olivan Javier | Chief Operating Officer |
Sep 28 '26 |
Sale |
750.42 |
946 |
709,902 |
8,824 |
| Zuckerberg Mark | COB and CEO |
Sep 24 '26 |
Sale |
777.44 |
27,474 |
21,359,454 |
0 |
| Zuckerberg Mark | Officer |
Sep 24 '26 |
Proposed Sale |
777.44 |
27,474 |
21,359,454 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):